Natus Medical's (BABY) CEO James Hawkins on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 2:03PM CDT
BABY: 41.64 (+1.71)
Adding Up Baby Steps at Natus Medical Inc.
Brian Orelli, The Motley Fool - Motley Fool - Wed Apr 22, 1:51PM CDT
Without any large acquisitions to help artificially boost sales as we've seen in the past, Natus Medical , a purveyor of medical devices specializing in neurology and care for newborns, keeps chugging along. Revenue in the first quarter increased...
BABY: 41.64 (+1.71)
Natus Medical Incorporated (BABY) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Apr 22, 9:55AM CDT
BABY: 41.64 (+1.71)
Natus Medical updates guidance after Q1 results
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:56AM CDT
BABY: 41.64 (+1.71)
Natus Medical beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:06AM CDT
BABY: 41.64 (+1.71)
Natus Medical Announces Record First Quarter 2015 Financial Results
GlobeNewswire - Wed Apr 22, 6:00AM CDT
-- Reports record first quarter non-GAAP earnings per share of $0.31
BABY: 41.64 (+1.71)
Natus Medical beats 1Q profit forecasts
Automated Insights - Wed Apr 22, 5:16AM CDT
PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported first-quarter net income of $8.6 million.
BABY: 41.64 (+1.71)
Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 4:30PM CDT
DHI: 27.03 (-1.53), MKTX: 88.66 (-1.35), NLSN: 46.10 (+0.27), SEIC: 45.99 (+0.68), AZZ: 46.11 (-0.02), HBAN: 11.03 (-0.14), TDY: 109.69 (+0.48), PCH: 37.47 (-0.65), WERN: 30.29 (-1.11), NS: 65.49 (+1.78), BABY: 41.64 (+1.71), APH: 56.81 (-1.35), TEL: 70.14 (+0.13), R: 97.95 (+1.15), ANGI: 6.46 (+0.31), EVR: 50.80 (+1.28), CFG: 25.49 (+0.45), SIX: 49.97 (+1.37), EMC: 27.13 (+0.81), OC: 42.28 (-0.61), WAB: 98.61 (+2.84), BK: 42.43 (+1.39), KO: 41.31 (+0.53), LAD: 102.54 (+0.04), ABT: 48.35 (+1.23), TMO: 130.69 (-3.75), TROW: 82.59 (-0.21), SONS: 7.89 (+0.05), ALV: 120.22 (-3.47), GNTX: 18.26 (+0.09), BA: 151.19 (-2.14), TUP: 67.25 (-2.60), KNX: 32.62 (+0.07), STJ: 73.55 (+4.43), MCD: 97.84 (+2.97), AN: 65.83 (+0.93)
Natus Medical (BABY) Showing Signs Of Being Strong And Under The Radar
at The Street - Tue Apr 21, 8:57AM CDT
Trade-Ideas LLC identified Natus Medical (BABY) as a strong and under the radar candidate
BABY: 41.64 (+1.71)
Natus Receives 510(k) FDA Clearance for the Quantum High Channel Count Amplifier
GlobeNewswire - Tue Apr 21, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) announced today that it has received FDA 510(k) clearance for the Quantum amplifier; an innovative high channel count amplifier that has applications in epilepsy and seizure monitoring along with research applications.
BABY: 41.64 (+1.71)
Next Week In Biotech: Amgen, AbbVie, Biogen Earnings, UniQure CHMP, AAN Meeting
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 17, 8:00AM CDT
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
ABT: 48.35 (+1.23), BIIB: 423.57 (+1.46), NEO: 4.83 (-0.04), SGMO: 14.37 (-0.03), IMGN: 9.96 (+0.01), AMGN: 169.10 (+0.64), ILMN: 190.04 (-9.27), SVA: 5.06 (+0.10), BCLI: 4.29 (-0.09), ISRG: 516.93 (-29.80), BABY: 41.64 (+1.71), QURE: 26.15 (-1.44), NURO: 1.32 (-0.02), ABAX: 63.25 (-0.09), GWPH: 113.04 (-0.05), ALXN: 188.19 (+1.41), ABBV: 64.52 (+0.91), AMAG: 57.68 (+0.47), CAT: 84.87 (+0.95), MAA: 76.57 (+1.00), NVS: 103.45 (-0.62)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 41.64 (+1.71), DHRM: 2.92 (+0.08), IVC: 19.80 (+0.24)
My Top Health Care Equipment And Supplies Stocks For 2015
Stan Stafford - at Seeking Alpha - Fri Apr 10, 12:52PM CDT
ZMH: 117.49 (+0.12), SIRO: 93.81 (+0.60), ABMD: 69.31 (-0.40), BDX: 144.33 (-1.24), MASI: 34.96 (+0.43), IRIX: 9.81 (-0.08), ALGN: 55.94 (-0.21), CYNO: 31.52 (+0.20), GB: 54.53 (-0.02), EW: 140.87 (+0.39), ANIK: 38.68 (+0.05), ERB: 3.04 (-0.30), BABY: 41.64 (+1.71), GMED: 25.09 (-0.16), BAX: 70.38 (+0.33), STJ: 73.55 (+4.43), INGN: 36.39 (-0.04)
BUYINS.NET: GD, BABY, HERO, CP, DD Expected To Be Up Before Next Earnings Releases
M2 - Fri Apr 10, 6:59AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and April earnings reports. General Dynamics Corp (NYSE:GD), NATUS MEDICAL, INCORPORATION (NASDAQ:BABY), Hercules Offshore Inc (NASDAQ:HERO), Canadian Pacific Railway Ltd (NYSE:CP), E. I. du Pont de Nemours and Co (NYSE
HERO: 0.66 (-0.05), BABY: 41.64 (+1.71), GD: 133.71 (+0.57), DD: 71.44 (+0.75), CP: 195.00 (+6.08)
Germany Blood Pressure Monitors Market Growth Trends 2007-2020 - Mercury BP Monitors, Aneroid BP Monitors & Automatic BP Monitors
M2 - Wed Apr 08, 8:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/22d49c/germany_blood) has announced the addition of the "Germany Blood Pressure Monitors Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the blood pressure monitors in Germany through 2020. The product categories covered in this report include: - Mercury BP Monitors - Aneroid BP Monitors - Automatic BP Monitors Scope - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments Key Topics Covered: 1 Table of Contents 1.1 List of Tables 1.2 List of Charts 2. Introduction 3. Scope of the Report 4. German Market for Blood Pressure Monitors, 2007-2020 4.1 Blood Pressure Monitors, Revenue ($ mn) by Sub-Category, 2007-2020 4.2 Blood Pressure Monitors, Volume (Units) by Sub-Category, 2007-2020 4.3 Blood Pressure Monitors, Average Price ($), 2007-2020 4.4 Blood Pressure Monitors, Company Shares (%), 2014 5. Recent Events and Developments 6. Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - GN ReSound A/S - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial Co., Ltd. - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Medical Corporation - Welch Allyn Inc. - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/22...many_blood
ABT: 48.35 (+1.23), MDT: 78.01 (+0.93), CAH: 91.50 (+1.15), COV: 106.71 (-1.36), EW: 140.87 (+0.39), MR: 31.77 (+0.62), BSX: 18.41 (+0.10), CMD: 92.72 (unch), BABY: 41.64 (+1.71), ALOT: 14.01 (+0.10), STJ: 73.55 (+4.43)
France Sleep Apnea Diagnostic Systems Market Growth Trends 2007-2020
M2 - Wed Apr 08, 8:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcwwpc/france_sleep) has announced the addition of the "France Sleep Apnea Diagnostic Systems Market Growth Trends, 2014" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the sleep apnea diagnostic systems in France through 2020. The product categories covered in this report include: - Fixed Polysomnography Systems - Portable Polysomnography Systems Scope - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments Key Topics Covered: 1 Table of Contents 1.1 List of Tables 1.2 List of Charts 2. Introduction 3. Scope of the Report 4. French Market for Sleep Apnea Diagnostic Systems, 2007-2020 4.1 Sleep Apnea Diagnostic Systems, Revenue ($ mn) by Sub-Category, 2007-2020 4.2 Sleep Apnea Diagnostic Systems, Volume (Units) by Sub-Category, 2007-2020 4.3 Sleep Apnea Diagnostic Systems, Average Price ($), 2007-2020 4.4 Sleep Apnea Diagnostic Systems, Company Shares (%), 2014 5. Recent Events and Developments 6. Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - Astro-Med, Inc. - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Embla Systems - ResMed Inc. - Natus Medical Incorporated - Nihon Kohden Corporation - Philips Medical Systems For more information visit http://www.researchandmarkets.com/research/bc...ance_sleep
ABT: 48.35 (+1.23), CAH: 91.50 (+1.15), COV: 106.71 (-1.36), EW: 140.87 (+0.39), BSX: 18.41 (+0.10), CMD: 92.72 (unch), BABY: 41.64 (+1.71), ALOT: 14.01 (+0.10), RMD: 73.28 (+0.17)
Natus Medical to Hold 2015 First Quarter Financial Results Conference Call on April 22nd
GlobeNewswire - Wed Apr 08, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company will release its 2015 first quarter financial results before the market opens on Wednesday, April 22. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
BABY: 41.64 (+1.71)
The Best Small Cap Stocks To Buy Now
Todd Campbell - at Seeking Alpha - Mon Apr 06, 4:40AM CDT
PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), AFFX: 12.57 (-0.13), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), EXAM: 42.52 (-0.16), IART: 59.75 (-0.26), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), CTRN: 24.27 (+0.16), ANAC: 66.45 (-0.22), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), FARO: 44.64 (-0.93), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), SNHY: 40.71 (+0.16), EBIX: 29.77 (+0.86), SWHC: 14.68 (-0.12)
Today's Strong And Under The Radar Stock: Natus Medical (BABY)
at The Street - Thu Apr 02, 12:57PM CDT
Trade-Ideas LLC identified Natus Medical (BABY) as a strong and under the radar candidate
BABY: 41.64 (+1.71)
The Best Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Mon Mar 30, 9:19AM CDT
OCR: 84.52 (+3.45), ELLI: 57.00 (-0.45), JCOM: 70.72 (-0.38), CAH: 91.50 (+1.15), AET: 107.95 (-0.41), BABY: 41.64 (+1.71), DFT: 32.24 (-0.18), NLNK: 53.12 (-0.07), HSIC: 141.11 (+1.14), MNK: 122.95 (-2.22), CAVM: 73.16 (+0.39), HAS: 71.73 (-1.82), BCR: 175.09 (+0.24), MCHP: 49.30 (+0.08), MYL: 72.40 (-1.67), NXPI: 102.69 (+1.45), EV: 43.60 (+0.19), NVDA: 22.31 (+0.25), LVLT: 54.24 (-0.04), CBRL: 137.40 (-1.10), MTSI: 34.46 (-0.27), AZO: 693.41 (+2.68), EQIX: 244.78 (+1.00), IRWD: 15.07 (-0.19), AVB: 170.64 (+1.59), KNX: 32.62 (+0.07), HAE: 42.33 (-0.21), FSL: 41.53 (+0.49), FHN: 14.49 (+0.06), BDX: 144.33 (-1.24), ACT: 295.22 (+0.69), F: 15.91 (+0.09), AON: 97.20 (+0.10), NUVA: 43.38 (+0.10), CDW: 38.93 (+0.21), ANTM: 152.84 (-0.04), APH: 56.81 (-1.35), INFA: 47.92 (-0.03), EXAM: 42.52 (-0.16), LII: 107.70 (+2.09), BJRI: 50.54 (-1.00), BDN: 14.90 (+0.14), DPZ: 99.80 (+0.40), FL: 60.00 (-0.08), DLX: 69.57 (+0.47), ABT: 48.35 (+1.23), BMR: 21.37 (+0.14), HCN: 75.44 (+0.21), DIOD: 28.02 (+0.12), LEG: 44.32 (unch), DIS: 107.94 (+0.26), GLW: 22.44 (-0.17), MAR: 80.78 (+0.31), ASML: 107.81 (+10.06), IMAX: 37.51 (+0.51), CNC: 70.90 (+0.12), CTAS: 82.05 (+0.01), FLO: 22.50 (-0.03), CRM: 67.71 (+0.33)